Publications by authors named "Christian Weyer"

Claim this Profile
T
The clinical approach to the detection of lipodystrophy - an AACE consensus statement.
Yehuda Handelsman, Elif A Oral, Zachary T Bloomgarden, Rebecca J Brown, Jean L Chan, Christian Weyer

Endocr Pract· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical effects of long-term metreleptin treatment in patients with lipodystrophy.
Jean L Chan, Karen Lutz, Elaine Cochran, Wenying Huang, Yvette Peters, Christian Weyer

Endocr Pract· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats.
James L Trevaskis, Chunli Lei, Joy E Koda, Christian Weyer, David G Parkes

Obesity (Silver Spring)· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
It takes two to tango: combined amylin/leptin agonism as a potential approach to obesity drug development.
Jean L Chan, Jonathan D Roth, Christian Weyer

J Investig Med· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced weight loss with pramlintide/metreleptin: an integrated neurohormonal approach to obesity pharmacotherapy.
Eric Ravussin, Steven R Smith, Julie A Mitchell, Reshma Shringarpure, Kevin Shan, Christian Weyer

Obesity (Silver Spring)· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.
James L Trevaskis, Todd Coffey, Rebecca Cole, Chunli Lei, Carrie Wittmer, Christian Weyer

Endocrinology· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity.
Steve R Smith, Louis J Aronne, Colleen M Burns, Nicole C Kesty, Amy E Halseth, Christian Weyer

Diabetes Care· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies.
Jonathan D Roth, Barbara L Roland, Rebecca L Cole, James L Trevaskis, Christian Weyer

Proc Natl Acad Sci U S A· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of islet-, gut-, and adipocyte-derived hormones in the central control of food intake and body weight: implications for an integrated neurohormonal approach to obesity pharmacotherapy.
Hubert C Chen, Jonathan D Roth, Brock E Schroeder, Christian Weyer

Curr Diabetes Rev· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals.
Juraj Koska, Norbert Stefan, Paska A Permana, Christian Weyer, Mina Sonoda

Am J Clin Nutr· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
Jonathan D Roth, Todd Coffey, Carolyn M Jodka, Holly Maier, Jennifer R Athanacio, Christian Weyer

Endocrinology· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study.
Louis Aronne, Ken Fujioka, Vanita Aroda, Kim Chen, Amy Halseth, Christian Weyer

J Clin Endocrinol Metab· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study.
Steven R Smith, John E Blundell, Colleen Burns, Cinzia Ellero, Brock E Schroeder, Christian Weyer

Am J Physiol Endocrinol Metab· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjects.
Ian Chapman, Barbara Parker, Selena Doran, Christine Feinle-Bisset, Judith Wishart, Christian Weyer

Obesity (Silver Spring)· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.
Jonathan Q Purnell, Christian Weyer

Treat Endocrinol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Properties of pramlintide and insulin upon mixing.
Christian Weyer, Mark S Fineman, Susan Strobel, Larry Shen, Joann Data

Am J Health Syst Pharm· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of pramlintide on postprandial glucose excursions and measures of oxidative stress in patients with type 1 diabetes.
Antonio Ceriello, Ludovica Piconi, Lisa Quagliaro, Yan Wang, Catherine A Schnabel, Christian Weyer

Diabetes Care· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancreatic polypeptide is involved in the regulation of body weight in pima Indian male subjects.
Juraj Koska, Angelo DelParigi, Barbora de Courten, Christian Weyer, P Antonio Tataranni

Diabetes· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
David G Maggs, Mark Fineman, Jonathan Kornstein, Terrie Burrell, Sherwyn Schwartz, Christian Weyer

Diabetes Metab Res Rev· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjects.
Tim Heise, Lutz Heinemann, Simon Heller, Christian Weyer, Yan Wang

Metabolism· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous glucose production, insulin sensitivity, and insulin secretion in normal glucose-tolerant Pima Indians with low birth weight.
Norbert Stefan, Christian Weyer, Claire Levy-Marchal, Michael Stumvoll, William C Knowler

Metabolism· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients.
Priscilla Hollander, David G Maggs, James A Ruggles, Mark Fineman, Larry Shen, Christian Weyer

Obes Res· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parasympathetic blockade attenuates augmented pancreatic polypeptide but not insulin secretion in Pima Indians.
Barbora Vozarova de Courten, Christian Weyer, Norbert Stefan, Mark Horton, Angelo DelParigi

Diabetes· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma adiponectin and endogenous glucose production in humans.
Norbert Stefan, Michael Stumvoll, Barbora Vozarova, Christian Weyer, Tohru Funahashi

Diabetes Care· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes: a dose-timing study.
Christian Weyer, Alan Gottlieb, Dennis D Kim, Karen Lutz, Sherwyn Schwartz

Diabetes Care· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis